Exact Sciences
EXAS
#1383
Rank
A$19.62 B
Marketcap
$106.24
Share price
2.34%
Change (1 day)
-8.55%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of June 2024 : A$10.00 B

According to Exact Sciences's latest financial reports the company's total assets are A$10.00 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$9.49 B3.8%
2022-12-31A$9.15 B-0.47%
2021-12-31A$9.19 B43.84%
2020-12-31A$6.39 B28.16%
2019-12-31A$4.98 B130.61%
2018-12-31A$2.16 B182.07%
2017-12-31A$0.76 B46.58%
2016-12-31A$0.52 B4.66%
2015-12-31A$0.49 B31%
2014-12-31A$0.38 B132.06%
2013-12-31A$0.16 B52.02%
2012-12-31A$0.10 B14.36%
2011-12-31A$94.55 M-0.81%
2010-12-31A$95.32 M230.85%
2009-12-31A$28.81 M237.4%
2008-12-31A$8.53 M-48.87%
2007-12-31A$16.7 M-44.83%
2006-12-31A$30.27 M-41.46%
2005-12-31A$51.72 M-28.67%
2004-12-31A$72.5 M55.4%
2003-12-31A$46.65 M-47.52%
2002-12-31A$88.89 M-28.1%
2001-12-31A$0.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$1.62 B-83.74%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.85 B-81.50%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.15 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$208.62 B 1,984.35%๐Ÿ‡ซ๐Ÿ‡ท France